About Company
- Legal Name: ABLYNX
- Registered country: Belgium
Description:
Belgian biotechnology company at Zwijnaarde near Ghent, acquired by Sanofi in 2018, which pioneered Nanobody therapeutics - small antibody fragments - and continues as Sanofi's Nanobody research and development centre.
Business Activities
Biopharmaceutical Products
Research InstituteBiotech / Biopharmaceutical Company
Finished Dosage Forms
Marketing Authorization Holder
Key Products/Services
Our Products & Services
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment